• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Variability of pharmacokinetic parameters for contraceptive steroids.

作者信息

Fotherby K

出版信息

J Steroid Biochem. 1983 Jul;19(1C):817-20. doi: 10.1016/0022-4731(83)90017-1.

DOI:10.1016/0022-4731(83)90017-1
PMID:6887900
Abstract

Studies of the pharmacokinetics of three contraceptive steroids, ethynyloestradiol, norethisterone and norethisterone oenanthate, in large groups of women are reviewed. Extremely wide variations were observed between women in the various calculated pharmacokinetic parameters. Studies carried out in small groups of subjects may give misleading results. It is difficult to ascribe any meaning and interpretation to most of the derived values but they do provide a means of comparing aspects of the metabolism of the various steroids. It is difficult to relate the pharmacokinetic values to the various biological actions of the steroids. However, the wide variations between subjects in the pharmacokinetic parameters must indicate equally wide variations in the biological activity of the steroids. Subjects in whom the bio-availability is low or where the rate of metabolism is rapid might be expected to respond differently, both in terms of efficacy and side-effects, from subjects with high values for bio-availability and a slow metabolism.

摘要

相似文献

1
Variability of pharmacokinetic parameters for contraceptive steroids.
J Steroid Biochem. 1983 Jul;19(1C):817-20. doi: 10.1016/0022-4731(83)90017-1.
2
Pharmacokinetics of norethisterone in humans.
Contraception. 1987 May;35(5):465-75. doi: 10.1016/0010-7824(87)90083-7.
3
Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.托吡酯对癫痫患者口服含炔诺酮和炔雌醇复方避孕药药代动力学的影响。
Epilepsia. 1997 Mar;38(3):317-23. doi: 10.1111/j.1528-1157.1997.tb01123.x.
4
Pharmacokinetics of different doses of norethisterone oenanthate.不同剂量庚酸炔诺酮的药代动力学
Contraception. 1984 Apr;29(4):325-33. doi: 10.1016/0010-7824(84)90066-0.
5
Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.低剂量口服避孕药在接受腹膜透析的慢性肾衰竭女性中的单剂量和多剂量药代动力学。
Am J Obstet Gynecol. 1993 May;168(5):1400-6. doi: 10.1016/s0002-9378(11)90772-8.
6
Influence of nutritional status on pharmacokinetics of contraceptive progestogens.营养状况对避孕孕激素药代动力学的影响。
Nutr Rev. 1984 May;42(5):182-3. doi: 10.1111/j.1753-4887.1984.tb02317.x.
7
Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.加巴喷丁与醋酸炔诺酮和炔雌醇的避孕方案无相互作用。
Neurology. 1998 Apr;50(4):1146-8. doi: 10.1212/wnl.50.4.1146.
8
Clinical pharmacokinetics of oral contraceptive steroids.口服避孕甾体激素的临床药代动力学。
Clin Pharmacokinet. 1983 Mar-Apr;8(2):95-136. doi: 10.2165/00003088-198308020-00001.
9
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.一项关于含不同类型及剂量孕激素的避孕制剂对血压影响的前瞻性对照研究。
Br J Obstet Gynaecol. 1984 Dec;91(12):1254-60. doi: 10.1111/j.1471-0528.1984.tb04747.x.
10
Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.四种口服避孕药配方与一种避孕阴道环的代谢及临床效果比较。
Am J Obstet Gynecol. 1980 Apr 1;136(7):920-31. doi: 10.1016/0002-9378(80)91052-2.

引用本文的文献

1
Pharmacogenomics of the Etonogestrel Contraceptive Implant: A Genome-Wide Association Study of Steady-State Etonogestrel Concentrations.依托孕烯避孕植入剂的药物基因组学:依托孕烯稳态浓度的全基因组关联研究
O G Open. 2025 Feb 27;2(1):e066. doi: 10.1097/og9.0000000000000066. eCollection 2025 Feb.
2
Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.左炔诺孕酮埋植剂使用者血药浓度与出血模式的关系。
Obstet Gynecol. 2019 Oct;134(4):807-813. doi: 10.1097/AOG.0000000000003452.
3
Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.
避孕埋植剂使用者的个体特征与依伴侬血药浓度的关系。
Contraception. 2019 Jul;100(1):37-41. doi: 10.1016/j.contraception.2019.03.045. Epub 2019 Apr 10.
4
Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.遗传变异对避孕埋植剂使用者中依托孕烯稳态浓度的影响。
Obstet Gynecol. 2019 Apr;133(4):783-794. doi: 10.1097/AOG.0000000000003189.
5
Drug interactions between hormonal contraceptives and antiretrovirals.激素避孕药与抗逆转录病毒药物之间的药物相互作用。
AIDS. 2017 Apr 24;31(7):917-952. doi: 10.1097/QAD.0000000000001392.
6
Estimating systemic exposure to ethinyl estradiol from an oral contraceptive.评估口服避孕药中炔雌醇的全身暴露量。
Am J Obstet Gynecol. 2015 May;212(5):614.e1-7. doi: 10.1016/j.ajog.2014.12.007. Epub 2014 Dec 12.
7
The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.仅可注射的避孕药醋酸甲羟孕酮与醋酸炔诺酮和孕酮不同,它通过糖皮质激素受体调节宫颈内细胞的炎症基因。
PLoS One. 2014 May 19;9(5):e96497. doi: 10.1371/journal.pone.0096497. eCollection 2014.
8
Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.涉及17α-乙炔雌二醇的药代动力学药物相互作用:对一种老药的新审视。
Clin Pharmacokinet. 2007;46(2):133-57. doi: 10.2165/00003088-200746020-00003.
9
Individual variation in first-pass metabolism.首过代谢的个体差异。
Clin Pharmacokinet. 1993 Oct;25(4):300-28. doi: 10.2165/00003088-199325040-00005.
10
Levonorgestrel. Clinical pharmacokinetics.左炔诺孕酮。临床药代动力学。
Clin Pharmacokinet. 1995 Mar;28(3):203-15. doi: 10.2165/00003088-199528030-00003.